Oncolys Biopharma Inc.
Patent Owner
Stats
- 5 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Dec 10, 2015 most recent publication
Details
- 5 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 36 Total Citation Count
- Jun 28, 2000 Earliest Filing
- 9 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2015/0352,076 MOLECULARLY TARGETED COMBINATION DRUG FOR TUMOR TREATMENT AND PREVENTIONAbandonedJan 25, 14Dec 10, 15[A61K]
2010/0256,379 ANTI-VIRAL AGENT CONTAINING HETEROCYCLIC AROMATIC COMPOUND AS ACTIVE INGREDIENTAbandonedOct 22, 08Oct 07, 10[C07D]
2010/0150,884 Anticancer Agent to Be Combined with TelomelysinAbandonedFeb 10, 06Jun 17, 10[A61K, A61P]
2009/0181,931 ANTIVIRAL ACTIVITY OF CIDOFOVIR AGAINST ONCOLYTIC VIRUSESAbandonedJan 16, 08Jul 16, 09[A61K, C12N, A61P]
2008/0032,283 TELOMELYSIN/GFP-EXPRESSING RECOMBINANT VIRUSAbandonedApr 05, 07Feb 07, 08[A61K, C12Q, C12N, A61P]
2006/0239,967 Oncolytic virus replicating selectively in tumor cellsAbandonedJul 07, 03Oct 26, 06[A61K, C12N]
2004/0248,132 DR5 gene promoter and siah-1 gene promoterAbandonedApr 02, 04Dec 09, 04[C07H, C12Q, C12N]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.